These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 20272558)

  • 1. The effect of castration and di-ethyl stilboestrol in a patient with myelophthisic anemia secondary to carcinoma of the prostate.
    COMMONS RR; STRAUSS MB
    J Clin Invest; 1947 Nov; 26(6):1178. PubMed ID: 20272558
    [No Abstract]   [Full Text] [Related]  

  • 2. Myelophthisic anemia the presenting manifestation of prostatic carcinoma with skeletal metastases; the effect of castration and stilbestrol.
    COMMONS RR; STRAUSS MB
    Am J Med Sci; 1948 May; 215(5):525-9. PubMed ID: 18101771
    [No Abstract]   [Full Text] [Related]  

  • 3. The effects of castration and stilboestrol on prostatic tumours in mice.
    HORNING ES
    Br J Cancer; 1949 Jun; 3(2):211-30. PubMed ID: 18132112
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of orchiectomy and various doses of stilbestrol on plasma testosterone levels in patients with carcinoma of the prostate.
    Mackler MA; Liberti JP; Smith MJ; Prout GR
    Surg Forum; 1970; 21():540-1. PubMed ID: 5535268
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of orchiectomy and various doses of stilbestrol on plasma testosterone levels in patients with carcinoma of the prostate.
    Mackler MA; Liberti JP; Smith MJ; Koontz WW; Prout GR
    Invest Urol; 1972 Mar; 9(5):423-5. PubMed ID: 5016026
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiovascular complications in the treatment of prostatic carcinoma.
    Glashan RW; Robinson MR
    Br J Urol; 1981 Dec; 53(6):624-7. PubMed ID: 7317753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metastases in bone marrow and myelophthisic anemia from carcinoma of the prostate.
    RUNDLES RW; JONSSON U
    Am J Med Sci; 1949 Sep; 218(3):241-50. PubMed ID: 18137147
    [No Abstract]   [Full Text] [Related]  

  • 8. Exceptional Response to Pembrolizumab in a Patient With Castration-Resistant Prostate Cancer With Pancytopenia From Myelophthisis.
    Vlachostergios PJ; Geyer JT; Miller J; Kosloff R; Beltran H; Tagawa ST
    J Oncol Pract; 2019 Jun; 15(6):343-345. PubMed ID: 30964731
    [No Abstract]   [Full Text] [Related]  

  • 9. Reconsideration of orchiectomy in the treatment of advanced prostatic carcinoma.
    Jordan WP; Blackard CE; Byar DP
    South Med J; 1977 Dec; 70(12):1411-3. PubMed ID: 594790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response to chemically induced prostatic tumors in rats to stilbestrol and orchiectomy.
    Butz GW; Cooper TP; Barham R; Ansell JS
    Surg Forum; 1976; 27(62):590-2. PubMed ID: 1019987
    [No Abstract]   [Full Text] [Related]  

  • 11. Carcinoma of prostate. Increased mortality and cardio-vascular complications associated with oestrogen therapy as compared with orchiectomy.
    Gardner AM; Setakis N
    Bristol Med Chir J; 1983 Jul; 98(367):117-9. PubMed ID: 6616292
    [No Abstract]   [Full Text] [Related]  

  • 12. Bone changes and variations in skeletal metastases due to diethylstilbestrol and orchiectomy during treatment of cancer of the prostate.
    WATTENBERG CA
    J Urol; 1947 Nov; 58(5):378-83. PubMed ID: 20270530
    [No Abstract]   [Full Text] [Related]  

  • 13. Bilateral orchiectomy in the treatment of carcinoma of the prostate.
    O'CONOR VJ; SOKOL JK
    Am J Surg; 1960 Apr; 99():573-9. PubMed ID: 13854138
    [No Abstract]   [Full Text] [Related]  

  • 14. The effects of castration and stilboestrol treatment on the semen production of the boar.
    WALLACE C
    J Endocrinol; 1949 Oct; 6(2):205-17, pl. PubMed ID: 15392913
    [No Abstract]   [Full Text] [Related]  

  • 15. Influence of diethylstilbestrol, Leuprolelin (a luteinizing hormone-releasing hormone analog), Finasteride (a 5 alpha-reductase inhibitor), and castration on the lobar subdivisions of the rat prostate.
    Yamashita A; Hayashi N; Sugimura Y; Cunha GR; Kawamura J
    Prostate; 1996 Jul; 29(1):1-14. PubMed ID: 8685049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative follow-up study of the therapeutic value of bilateral orchiectomy in the treatment of carcinoma of the prostate gland.
    SCOTT WW; BENJAMIN JA
    J Urol; 1948 Oct; 60(4):604-11. PubMed ID: 18885948
    [No Abstract]   [Full Text] [Related]  

  • 17. Orchiectomy and delayed radiotherapy as treatment for prostatic carcinoma. A 10-year survey.
    Meffan PM; Nacey JN
    Br J Urol; 1986 Aug; 58(4):417-22. PubMed ID: 3756411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carcinoma of the prostate gland, and benefits of diethylstilbestrol or orchiectomy.
    WATTENBERG CA
    Mo Med; 1945 Aug; 42():482-5. PubMed ID: 21007328
    [No Abstract]   [Full Text] [Related]  

  • 19. Complete androgen blockade: the EORTC experience comparing orchidectomy versus orchidectomy plus cyproterone acetate versus low-dose stilboestrol in the treatment of metastatic carcinoma of the prostate.
    Robinson MR
    Prog Clin Biol Res; 1987; 243A():383-90. PubMed ID: 2958863
    [No Abstract]   [Full Text] [Related]  

  • 20. Some effects of hormone therapy and castration of the hypophysis in men with carcinoma of the prostate.
    RUSSFIELD AB; BYRNES RL
    Cancer; 1958; 11(4):817-28. PubMed ID: 13561251
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.